Of all demographic groups, women between the ages of 50 and 64 had the highest use rate: One in five women, or 20 percent, reported having ever used GLP-1 agonists
Discussion Kidney disorders are significant global health issues with significant financial implications
Metabolism 161:156057 Scheen AJ (2025) GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies
But bodybuilders, longevity buffs, health podcasters, and biohackers are reeling after the FDA recently banned 17 other popular peptides
Melanie Avalon: my audience, they know me for skincare
Theyll do this by saying your serum B12 levels are high now so you must be well whilst ignoring the fact that youre a depressed, exhausted, broken heap on the floor